King and Queen of the Netherlands to pay working visit to United States: Georgia and New York – program
May 28, 2024 16:22 ET
|
Embassy of the Kingdom of the Netherlands
Washington, D.C., May 28, 2024 (GLOBE NEWSWIRE) -- His Majesty King Willem-Alexander and Her Majesty Queen Máxima are to travel to the United States for a working visit to the states of Georgia and...
COP28: Statkraft and Aquabattery partner to develop flow batteries made with salt water
December 05, 2023 05:37 ET
|
Statkraft AS
(Dubai/Oslo/Delft, 5 December 2023) Norwegian renewables company Statkraft and Dutch climate tech start-up Aquabattery partner to develop a promising technology to improve long-term storage of...
Mendus AB: Mendus erhåller slutbetalning som ett resultat av EU Horizon 2020 AML-VACCiN-projektets slutförande
October 12, 2022 02:00 ET
|
Mendus AB
HORIZON 2020 BEVILJADE STÖD FÖR MENDUS ATT ETABLERA ETT STARKT EUROPEISKT FORSKNINGS- OCH KLINISKT NÄTVERK FÖR UTVECKLING AV DCP-001 I AML Mendus AB (“Mendus” publ; IMMU.ST), ett...
Mendus AB: Mendus to receive final payment as a result of the completion of the EU Horizon 2020 AML-VACCiN project
October 12, 2022 02:00 ET
|
Mendus AB
HORIZON 2020 GRANT SUPPORTED MENDUS IN ESTABLISHING A STRONG EUROPEAN RESEARCH AND CLINICAL NETWORK FOR THE DEVELOPMENT OF DCP-001 IN AML Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical...
Merck Recognized for Responsible Entrepreneurship in the Netherlands
May 19, 2022 15:39 ET
|
Embassy of the Kingdom of the Netherlands
Washington, D.C., May 19, 2022 (GLOBE NEWSWIRE) -- On May 19, the Embassy of the Kingdom of the Netherlands presented the 2022 Holland on the Hill Heineken Award to New Jersey-based...
Immunicum meddelar lovande resultat avseende överlevnad i fas II-studien MERECA med ilixadencel i njurcancer
February 22, 2021 02:00 ET
|
Immunicum AB
Pressmeddelande 22 februari 2021 Immunicum meddelar lovande resultat avseende överlevnad i fas II-studien MERECA med ilixadencel i njurcancer - Medianöverlevnad för patientgruppen som behandlades...
Immunicum Announces Encouraging Signs of Survival Benefit in Phase II MERECA Trial of Ilixadencel in Kidney Cancer
February 22, 2021 02:00 ET
|
Immunicum AB
Press Release 22 February 2021 Immunicum Announces Encouraging Signs of Survival Benefit in Phase II MERECA Trial of Ilixadencel in Kidney Cancer -- Median Overall Survival (OS) for the...
Immunicum AB (publ) planerar att expandera bolagets anläggning för forskning och processutveckling i Leiden, Nederländerna
January 27, 2021 02:00 ET
|
Immunicum AB
27 januari 2021 Immunicum AB (publ) planerar att expandera bolagets anläggning för forskning och processutveckling i Leiden, Nederländerna Immunicum AB (publ; IMMU.ST) meddelar idag att de...
Immunicum AB (publ) Plans to Expand its Research and Process Development Facilities in Leiden, the Netherlands
January 27, 2021 02:00 ET
|
Immunicum AB
Press Release 27 January 2021 Immunicum AB (publ) Plans to Expand its Research and Process Development Facilities in Leiden, the Netherlands Immunicum AB (publ; IMMU.ST) announced today that...
ValueSelling Associates Welcomes Sales Industry Expert Bart van Eijck
September 17, 2020 14:50 ET
|
ValueSelling Associates, Inc.
RANCHO SANTA FE, Calif., Sept. 17, 2020 (GLOBE NEWSWIRE) -- ValueSelling Associates, Inc. announces its partnership with Bart van Eijck to expand the reach of ValueSelling’s sales training and sales...